NCT05587673View on ClinicalTrials.gov

High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 6, 2022

Primary Completion Date

October 11, 2023

Study Completion Date

October 11, 2024

Conditions
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative ColitisIndeterminate Colitis
Interventions
DRUG

Methylprednisolone

High dose steroid injected directly into the inflamed bowel segment(s) via its arterial blood supply.

Trial Locations (1)

94304

Stanford University, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER